Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients. [electronic resource]
Producer: 20101019Description: 1079-88 p. digitalISSN:- 1558-3597
- Acetates -- administration & dosage
- Acute Coronary Syndrome -- diagnosis
- Aged
- Atorvastatin
- Biomarkers -- blood
- C-Reactive Protein -- analysis
- Cholesterol, LDL -- analysis
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Heptanoic Acids -- administration & dosage
- Humans
- Indoles -- administration & dosage
- Keto Acids
- Logistic Models
- Male
- Middle Aged
- Phospholipases A2, Secretory -- blood
- Prospective Studies
- Pyrroles -- administration & dosage
- Reference Values
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.